| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 253 | 2017 |
| Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis J Bolaños-Meade, M Hamadani, J Wu, MM Al Malki, MJ Martens, ... New England Journal of Medicine 388 (25), 2338-2348, 2023 | 131 | 2023 |
| Biologic assignment trial of reduced-intensity hematopoietic cell transplantation based on donor availability in patients 50-75 years of age with advanced myelodysplastic syndrome R Nakamura, W Saber, MJ Martens, A Ramirez, B Scott, B Oran, E Leifer, ... Journal of Clinical Oncology 39 (30), 3328-3340, 2021 | 95 | 2021 |
| Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial J Pidala, M Hamadani, P Dawson, M Martens, AM Alousi, M Jagasia, ... Blood, The Journal of the American Society of Hematology 135 (2), 97-107, 2020 | 68 | 2020 |
| Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning … SG Holtan, M Hamadani, J WU, MM AL Malki, L Runaas, H Elmariah, ... Blood 140 (Supplement 2), LBA-4-LBA-4, 2022 | 50 | 2022 |
| Patient-reported outcomes and socioeconomic status as predictors of clinical outcomes after hematopoietic stem cell transplantation: a study from the Blood and Marrow … JM Knight, KL Syrjala, NS Majhail, M Martens, J Le-Rademacher, ... Biology of Blood and Marrow Transplantation 22 (12), 2256-2263, 2016 | 29 | 2016 |
| Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia E Segal, M Martens, HL Wang, R Brazauskas, D Weisdorf, BM Sandmaier, ... Cancer 123 (17), 3346-3355, 2017 | 27 | 2017 |
| Allogeneic hematopoietic cell transplantation in multiple myeloma: impact of disease risk and post allograft minimal residual disease on survival B Dhakal, A D'Souza, M Martens, J Kapke, AM Harrington, M Pasquini, ... Clinical Lymphoma Myeloma and Leukemia 16 (7), 379-386, 2016 | 23 | 2016 |
| Factors associated with successful discontinuation of immune suppression after allogeneic hematopoietic cell transplantation J Pidala, M Martens, C Anasetti, J Carreras, M Horowitz, SJ Lee, J Antin, ... JAMA oncology 6 (1), e192974-e192974, 2020 | 22 | 2020 |
| A multi-center biologic assignment trial comparing reduced intensity allogeneic hematopoietic cell transplantation to hypomethylating therapy or best supportive care in … R Nakamura, W Saber, MJ Martens, A Ramirez, BL Scott, B Oran, E Leifer, ... Blood 136, 19-21, 2020 | 21 | 2020 |
| Acute GVHD diagnosis and adjudication in a multicenter trial: a report from the BMT CTN 1202 Biorepository Study R Reshef, W Saber, J Bolaños-Meade, G Chen, YB Chen, VT Ho, ... Journal of Clinical Oncology 39 (17), 1878, 2021 | 18 | 2021 |
| Allogeneic transplantation for relapsed Waldenström macroglobulinemia and lymphoplasmacytic lymphoma RF Cornell, V Bachanova, A D'Souza, K Woo-Ahn, M Martens, J Huang, ... Biology of Blood and Marrow Transplantation 23 (1), 60-66, 2017 | 18 | 2017 |
| Allogeneic hematopoietic cell transplantation improves outcome in myelodysplastic syndrome across high-risk genetic subgroups: genetic analysis of the Blood and Marrow … J Versluis, W Saber, HK Tsai, CJ Gibson, LW Dillon, A Mishra, J McGuirk, ... Journal of Clinical Oncology 41 (28), 4497-4510, 2023 | 17 | 2023 |
| SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study JA Hill, MJ Martens, JAH Young, K Bhavsar, J Kou, M Chen, LW Lee, ... Eclinicalmedicine 59, 2023 | 17 | 2023 |
| Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study NS Bhatt, A Sharma, AS Martin, MB Abid, VI Brown, MAD Perez, ... Transplantation and Cellular Therapy 28 (10), 696. e1-696. e7, 2022 | 17 | 2022 |
| Pretransplantation exercise and hematopoietic cell transplantation survival: a secondary analysis of blood and marrow transplant clinical trials network (BMT CTN 0902) JR Wingard, WA Wood, M Martens, J Le-Rademacher, B Logan, ... Biology of Blood and Marrow Transplantation 23 (1), 161-164, 2017 | 17 | 2017 |
| Low information omnibus (LIO) priors for Dirichlet process mixture models Y Shi, M Martens, A Banerjee, P Laud Bayesian Analysis 14 (3), 677-702, 2019 | 15 | 2019 |
| Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome … R Cusatis, MJ Martens, R Nakamura, CS Cutler, W Saber, SJ Lee, ... American Journal of Hematology 98 (2), 229-250, 2023 | 14 | 2023 |
| Increasing use of allogeneic hematopoietic cell transplantation (HCT) in patients age 70 years and older: a CIBMTR study of trends and outcomes L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Biology of Blood and Marrow Transplantation 22 (3), S68-S69, 2016 | 14 | 2016 |
| A unified approach to sample size and power determination for testing parameters in generalized linear and time‐to‐event regression models MJ Martens, BR Logan Statistics in Medicine 40 (5), 1121-1132, 2021 | 8 | 2021 |
